In the news…
PharmaCyte Biotech Addresses Development of Targeted Cannabinoid Chemotherapy.
March 1, 2016
PharmaCyte Biotech’s Dr. Mark Rabe Discusses the Significance of Schedule 1 License to Company’s Future in Cannabis Research.
June 18, 2015
PharmaCyte Biotech Advances Cannabinoid Research With Schedule 1 License.
June 15, 2015
Pot Med is Life Changer for Tiny Sadie.
April 28, 2015
Stock Spotlight on Pharmacyte Biotech Inc (OTCMKTS:PMCB).
January 18, 2015
Nuvilex Announces Name Change of Subsidiary to Viridis Biotech.
December 8, 2014
Nuvilex Obtains Exclusive Worldwide License to Develop Disease Treatments That Combine Cell-in-a-Box(R) and Cannabinoid-Based Medicine.
December 1, 2014
Nuvilex, Inc. Engaged in “Cutting Edge” Cannabis Preclinical Studies Using Model Compounds With Cell-in-a-Box.
October 29, 2014
Did Marijuana Smoking Give These Young Men Heart Attacks?.
August 15, 2014
University of Northern Colorado Team at Cutting Edge of Research on Cannabis-based Cancer Treatments.
July 25, 2014
Can pot fight cancer? UNC seeks the answer.
July 25, 2014
Nuvilex and Austrianova Announce Results of Clinical Trial in Dogs with Mammary Tumors Treated With Cell-in-a-Box(R) Plus Cyclophosphamide.
July 17, 2014
Nuvilex Provides Shareholder Update on Milestone Accomplishments.
July 14, 2014
Chronic Pain and the Therapeutic Benefits of Medical Cannabis.
June 13, 2014
Nuvilex And Medical Marijuana Sciences: Furthering Cancer Research.
June 10, 2014
Nuvilex and Translational Drug Development (TD2) Begin Preparations for US-Based Studies on Symptoms Associated With Pancreatic Cancer.
May 21, 2014
Nuvilex: A Biotech Methodically Pursuing Cannabis Treatments for Cancer.
May 13, 2014
Nuvilex Signs Agreement with the University of Northern Colorado to Study Development of Cannabis-Based Cancer Treatments.
May 9, 2014
Medical Marijuana Sciences’ Scientific Advisory Board Chairman Dr. Mark L. Rabe Educates Professional Fiduciaries on the Benefits of Medical Marijuana.
April 28, 2014
Medical Marijuana Sciences’ Scientific Advisory Board Chairman Dr. Mark L. Rabe Presents to Pain Medicine and Other Physicians at the University of California San Diego.
April 25, 2014
Medical Marijuana Sciences’ Dr. Mark L. Rabe Speaks at ASA Medical Cannabis Unity Conference in Washington DC.
April 8, 2014
Nuvilex to Present at ASA National Medical Cannabis Unity Conference in Washington, DC
March 25, 2014
Ramona Couple Found Not Guilty in Medical Cannabis Case
March 19, 2014
Jury Deliberating in Medical Marijuana Trial – Day 5 and 6 of People v Dennis and Deborah Little
March 14, 2014
Nuvilex Appoints CEO and President of Austrianova to Scientific Advisory Board
March 11, 2014
CNN: Minister’s daughter: Cannabis ‘a gift from God’
March 7, 2014
Nuvilex Appoints Dr. Garret L. Yount to Its Subsidiary’s Scientific Advisory Board
March 7, 2014
CNN Chief Medical Correspondent Dr. Sanjay Gupta: ‘I am doubling down’ on medical marijuana.
March 6, 2014
Congressional Legislators Agree With Nuvilex’s Dr. Mark Rabe on Reclassifying Marijuana
February 14, 2014
Nuvilex’s Dr. Mark Rabe Talks Medical Marijuana, Legalization and Cell-in-a-Box
February 12, 2014
Nuvilex, Inc. Subsidiary Medical Marijuana Sciences, Inc. Appoints University of Northern Colorado Professor, Richard M. Hyslop, Ph.D., to Scientific Advisory Board
January 6, 2014
Dr. Mark L. Rabe Develops Charter for Scientific Advisory Board of Nuvilex’s Subsidiary, Medical Marijuana Sciences, Inc.
December 30, 2013
Nuvilex Lands Leading Figure in Medical Marijuana Field as Chairman of Subsidiary’s Scientific Advisory Board
December 23, 2013
Nuvilex’s Subsidiary, Medical Marijuana Sciences, Inc., Appoints Dr. Mark L. Rabe as Chairman of Its Scientific Advisory Board
December 6, 2013
CNN’s Dr. Sanjay Gupta: Why I Changed My Mind on Weed
August 8, 2013